Related Experiment Video
Updated: Jun 5, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction
1Division of Urology, Department of Surgery, University of Pennsylvania School of Medicine, 3400 Civic Center Blvd., 3 West Perelman, Philadelphia, Pennsylvania 19104, USA. ariana.smith@uphs.upenn.edu
Discovery Medicine
|December 30, 2010
Summary
Estrogen replacement therapy may help post-menopausal women with genitourinary symptoms. This review examines evidence from clinical trials on its effectiveness for conditions like vaginal atrophy and urinary incontinence.
Area of Science:
- Gynecology
- Urology
- Menopause Research
Background:
- Post-menopausal genitourinary symptoms are common.
- Estrogen depletion is linked to these symptoms.
- Estrogen replacement therapy (ERT) is debated for efficacy and safety.
Purpose of the Study:
- To review indications for ERT in post-menopausal women.
- To evaluate evidence for ERT in treating genitourinary symptoms.
- To analyze key clinical trials on ERT and urogenital health.
Main Methods:
- Review of Level 1 evidence from randomized controlled trials.
- Analysis of studies focusing on urinary incontinence.
- Examination of research on overactive bladder, UTIs, vaginal atrophy, and dyspareunia.
Main Results:
- Evidence suggests ERT can improve genitourinary symptoms.
- Clinical trials provide valuable data on ERT's impact.
- Consensus on ERT use remains limited despite evidence.
Conclusions:
- ERT is indicated for specific genitourinary symptoms in post-menopausal women.
- Further research and clinical guidelines are needed.
- Balancing benefits and risks of ERT is crucial.
Related Concept Videos
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:28Microbiota of the Urogenital Tract
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
01:25Urinary Tract Infection II: Pathophysiology
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
01:26Urinary Tract Infection I: Introduction
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...